Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
menu
Home
Active Ingredients
Natalizumab
Natalizumab
Medicine
Status
Monitoring
SPC
PIL
XPIL
Legal Category
Active Ingredient(s)
Company
tyruko
SPC - EMA
Natalizumab
Sandoz GmbH
Tysabri 150 mg solution for injection in pre-filled syringe
Updated
SPC
PIL
No
B
Natalizumab
Biogen Idec (Ireland) Ltd
Tysabri 300mg concentrate for solution for infusion
Updated
SPC
PIL
No
B
Natalizumab
Biogen Idec (Ireland) Ltd
Cookies
Direct Healthcare Professional Communications
Documents associated with this medicine were updated in the last 30 days.
Product subject to medical prescription which may be renewed (B)
